Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6744 stock hub

TPEX/6744 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6744is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

254.1M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6744

In the news

Latest news · TPEX/6744

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E17.6

P25 14.4P50 18P75 31.9

ROE6

P25 -16.2P50 0.3P75 9.8

ROIC17.6

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6744 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

222

Groups with data

Currency

TWD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	32
Employees Change	4%
Employees Change Percent	14.29
Enterprise value	TWD 81.4M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006744006
Last refreshed	2026-05-10
Market cap	TWD 254.1M
Price	TWD 16.5
Price currency	TWD
Sector	Healthcare
Sic	8071
Symbol	tpex/6744
Website	https://www.fcbiotech.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.7%
EV Earnings	5.62x
EV/EBIT	5.88x
EV/EBITDA	3.13x
EV/FCF	-8.32x
EV/Sales	0.46x
FCF yield	-3.85%
P/B ratio	1.06x
P/E ratio	17.56x
P/S ratio	1.43x
PE Ratio10 Y	16.87x
PE Ratio3 Y	19.19x
PE Ratio5 Y	18.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.81%
EBITDA Margin	13.11%
Gross margin	44.63%
Gross Profit	TWD 79.2M
Gross Profit Growth	-0.48%
Gross Profit Growth Q	-1.07%
Gross Profit Growth3 Y	-0.49%
Gross Profit Growth5 Y	-0.72%
Net Income	TWD 14.5M
Net Income Growth	-12.78%
Net Income Growth Q	-17.11%
Net Income Growth Years	0%
Net Income Growth3 Y	-9.12%
Net Income Growth5 Y	-9.7%
Pretax Margin	9.55%
Profit Margin	8.16%
Profitable Years	7
ROA	2.95
Roa5y	4.55
ROCE	5.71
ROE	6.03
Roe5y	8.66
ROIC	17.61
Roic5y	142.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-2.81%
Cagr3y	-13.22%
Cagr5y	-5.48%
Div CAGR3	-8.74%
Div CAGR5	1.09%
EPS Growth	-12.16
EPS Growth Q	-16.83
EPS Growth Years	0
EPS Growth3 Y	-8.84
EPS Growth5 Y	-9.7
FCF Growth Q	-34.39%
OCF Growth	-87.08%
OCF Growth Q	-73.84%
OCF Growth10 Y	-22.09%
OCF Growth3 Y	-44.16%
OCF Growth5 Y	-37.65%
Revenue Growth	3.66x
Revenue Growth Q	-3.07x
Revenue Growth Years	1x
Revenue Growth3 Y	0.75x
Revenue Growth5 Y	-0.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.6
Assets	TWD 287.9M
Cash	TWD 178.1M
Current Assets	TWD 232.6M
Current Liabilities	TWD 45.2M
Debt	TWD 5.4M
Debt EBITDA	TWD 0.21
Debt Equity	TWD 0.02
Debt FCF	TWD -0.55
Equity	TWD 239.9M
Interest Coverage	76.5
Liabilities	TWD 48M
Long Term Assets	TWD 55.3M
Long Term Liabilities	TWD 2.8M
Net Cash	TWD 172.7M
Net Cash By Market Cap	TWD 67.97
Net Cash Growth	-13.23%
Net Debt EBITDA	TWD -7.43
Net Debt Equity	TWD -0.72
Tangible Book Value	TWD 239.8M
Tangible Book Value Per Share	TWD 15.57
WACC	5.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.14
Inventory Turnover	3.65
Net Working Capital	TWD 12M
Quick ratio	4.28
Working Capital	TWD 187.4M
Working Capital Turnover	TWD 0.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.08%
Dividend Growth	-9.52%
Dividend Growth Years	0%
Dividend per share	TWD 0.95
Dividend Years	7
Dividend Yield	5.76%
Ex Div Date	2025-07-22
Last Dividend	TWD 0.95
Payout Frequency	Annual
Payout Ratio	101.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-2.81%
200-day SMA	18.26
3Y total return	-34.65%
50-day SMA	16.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-24.55%
All Time High	71
All Time High Change	-76.76%
All Time High Date	2020-05-22
All Time Low	13.3
All Time Low Change	24.06%
All Time Low Date	2026-04-08
ATR	0.98
Beta	0.32
Beta1y	-0.36
Beta2y	0.01
Ch YTD	-7.3
High	16.55
High52	22.1
High52 Date	2025-09-18
High52ch	-25.34%
Low	16.45
Low52	13.3
Low52 Date	2026-04-08
Low52ch	24.06%
Ma50ch	1.81%
Price vs 200-day SMA	-9.65%
RSI	49.61
RSI Monthly	39.59
RSI Weekly	45.26
Sharpe ratio	-0.03x
Sortino ratio	0.07
Total Return	5.84%
Tr YTD	-7.3
Tr1m	-3.51%
Tr1w	-1.2%
Tr3m	-5.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 13.8M
Operating Income Growth	-9.09
Operating Income Growth Q	-27.25
Operating Income Growth3 Y	-11.47
Operating Income Growth5 Y	-12.23
Operating margin	7.81

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,168,766%
Net Borrowing	-2,721,000
Shares Insiders	14.55%
Shares Out	15,400,000
Shares Qo Q	-0.03%
Shares Yo Y	-0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -9.8M
Average Volume	37,422.9x
Bv Per Share	15.58
CAPEX	TWD -13M
Ch1m	-3.51
Ch1w	-1.2
Ch1y	-7.3
Ch3m	-5.71
Ch3y	-43.69
Ch5y	-41.07
Ch6m	-15.17
Change	-0.9%
Change From Open	0
Close	16.65
Days Gap	-0.9
Depreciation Amortization	9,405,000
Dollar Volume	661,650
Earnings Date	2026-05-12
EBIT	TWD 13.8M
EBITDA	TWD 23.3M
EPS	TWD 0.94
F Score	6
FCF	TWD -9.8M
FCF EV Yield	-12.02x
FCF Per Share	TWD -0.64
Financing CF	-17,351,000
Fiscal Year End	December
Founded	1,992
Graham Number	18.15029
Graham Upside	10
Income Tax	TWD 2.5M
Investing CF	5,260,000
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2025-12-31
Lynch Fair Value	TWD 4.7
Lynch Upside	-71.52
Ma150	17.86
Ma150ch	-7.6%
Ma20	16.51
Ma20ch	-0.05%
Net CF	-8,855,000
Next Earnings Date	2026-05-12
Open	16.5
P OCF Ratio	78.52
Payment Date	2025-08-11
Position In Range	50
Ppne	32,878,000
Price Date	2026-05-08
Price EBITDA	TWD 10.93
Ptbv Ratio	1.06
Relative Volume	1.07x
Revenue	177,360,000x
Tax By Revenue	1.39x
Tax Rate	14.52%
Tr6m	-15.17%
Volume	40,100
Z Score	5.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/6744 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.8%

$0.95 annual per share

Payout ratio

+101.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.1%

0 consecutive years of growth

Total shareholder yield

+5.8%

Next ex-dividend date: 2025-07-22

Performance

TPEX/6744 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6744?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+14.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

TPEX/6744 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.6

Neutral momentum band

Price vs 200-day MA

-9.6%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

-0.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6744

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6744 stock rating?

tpex/6744 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6744 analysis?

The full report lives at /stocks/tpex/6744/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6744?

The latest report frames tpex/6744 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6744 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.